Immune Reconstitution after Haploidentical Donor and Umbilical Cord Blood Allogeneic Hematopoietic Cell Transplantation

por Elmariah, Hany, Brunstein, Claudio G., Bejanyan, Nelli
Publicado en Life (Basel) (2021)

Adoptive Immunotherapy using Regulatory T cells and Virus-specific T cells Derived from Cord Blood

por Hanley, Patrick J., Bollard, Catherine M., Brunstein, Claudio G
Publicado en Cytotherapy (2015)

Life-Threatening Hypertriglyceridemia in a Patient on Ruxolitinib and Sirolimus for Chronic Graft-versus-Host Disease

por Watson, Allison P., Brunstein, Claudio G., Holtan, Shernan G.
Publicado en Case Rep Transplant (2018)

Red Blood Cell Product Utilization in Patients Undergoing Allogeneic Stem Cell Transplantation

por Gastecki, Karen, Shanley, Ryan, Welbig, Julie, Cohn, Claudia, Brunstein, Claudio G.
Publicado en Transfusion (2019)

Donor-derived myelodysplastic syndrome and acute leukaemia after allogeneic haematopoietic stem cell transplantation: incidence, natural history and treatment response

por Dietz, Andrew C., DeFor, Todd E., Brunstein, Claudio G., Jr, John E. Wagner
Publicado 2014

Effect of Conditioning Regimen Intensity on Acute Myeloid Leukemia Outcomes after Umbilical Cord Blood Transplantation

por Oran, Betul, Wagner, John E., DeFor, Todd E., Weisdorf, Daniel J., Brunstein, Claudio G.
Publicado 2011

Relapse of lymphoma after allogeneic hematopoietic cell transplantation: Management strategies and outcome

por Wudhikarn, Kitsada, Brunstein, Claudio G., Bachanova, Veronika, Burns, Linda J, Cao, Qing, Weisdorf, Daniel J.
Publicado 2011

Anti-HLA Antibodies in Double Umbilical Cord Blood Transplantation

por Brunstein, Claudio G., Noreen, Harriet, DeFor, Todd E., Maurer, David, Miller, Jeffrey S., Wagner, John E.
Publicado 2011

BEAM Conditioning Is Well Tolerated and Yields Similar Survival in Obese and Non-Obese Patients with Lymphoma: No Requirement for Weight-Based Dose Modifications

por Fair, Christina, Shanley, Ryan, Rogosheske, John, Lazaryan, Aleksandr, McClune, Brian, Brunstein, Claudio G., Bachanova, Veronika
Publicado en Bone Marrow Transplant (2017)

Dendritic cell recovery predicts better survival after umbilical cord blood transplantation

por Touma, Waseem, Cao, Qing, Verneris, Michael R., Curtsinger, Julie, Miller, Jeffrey S., Brunstein, Claudio G., Bachanova, Veronika
Publicado en Biol Blood Marrow Transplant (2017)

Evaluation of post-thaw CFU-GM: clinical utility and role in quality assessment of umbilical cord blood in patients receiving single unit transplant

por Hussein, Eiman, DeFor, Todd, Wagner, John E., Sumstad, Darin, Brunstein, Claudio G., McKenna, David H.
Publicado en Transfusion (2019)

Hematopoietic Cell and Solid Organ Transplantation in the same patient: Long term experience at the University of Minnesota

por Jurdi, Najla El, DeFor, Todd, Adamusiak, Anna M, Brunstein, Claudio G, Pruett, Timothy, Weisdorf, Daniel J
Publicado en Transplant Cell Ther (2020)

Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignancies

por Eapen, Mary, O’Donnell, Paul, Brunstein, Claudio G., Wu, Jun, Barowski, Kate, Mendazibal, Adam, Fuchs, Ephraim J.
Publicado 2014

Nonparametric methods for analyzing recurrent gap time data with application to infections after hematopoietic cell transplant

por Lee, Chi Hyun, Luo, Xianghua, Huang, Chiung-Yu, DeFor, Todd E., Brunstein, Claudio G., Weisdorf, Daniel J.
Publicado en Biometrics (2015)

SEMIPARAMETRIC REGRESSION MODEL FOR RECURRENT BACTERIAL INFECTIONS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

por Lee, Chi Hyun, Huang, Chiung-Yu, DeFor, Todd E., Brunstein, Claudio G., Weisdorf, Daniel J., Luo, Xianghua
Publicado en Stat Sin (2019)

Monitoring and preemptive rituximab therapy for Epstein-Barr virus reactivation after anti-thymocyte globulin containing nonmyeloablative conditioning for umbilical cord blood tran...

por Blaes, Anne H., Cao, Qing, Wagner, John E., Young, Jo-Anne H., Weisdorf, Daniel J., Brunstein, Claudio G.
Publicado 2009

Adjusting Cyclophosphamide Dose in Obese Patients with Lymphoma Is Safe and Yields Favorable Outcomes after Autologous Hematopoietic Cell Transplantation

por Bachanova, Veronika, Rogosheske, John, Shanley, Ryan, Burns, Linda J., Smith, Sara M., Weisdorf, Daniel J., Brunstein, Claudio G.
Publicado en Biol Blood Marrow Transplant (2015)

Improving Outcomes After Allogeneic Hematopoietic Cell Transplantation for Hodgkin Lymphoma in the Brentuximab Vedotin Era

por Hegerova, Livia, Cao, Qing, Lazaryan, Aleksander, McClune, Brian L., Weisdorf, Daniel J., Brunstein, Claudio G., Bachanova, Veronika
Publicado en Bone Marrow Transplant (2017)

CXCR4 Expression in CD34+ Cells and Unit Predominance after Double Umbilical Cord Blood Transplantation

por Ramirez, Pablo, Wagner, John E., DeFor, Todd E., Eide, Cindy R., Miller, Jeffrey S., Weisdorf, Daniel J., Brunstein, Claudio G.
Publicado 2012

Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord b...

por Brunstein, Claudio G., Weisdorf, Daniel J., DeFor, Todd, Barker, Juliet N., Tolar, Jakub, van Burik, Jo-Anne H., Wagner, John E.
Publicado 2006